Immunotherapy of autochthomous rat methylcholanthrene-induced sarcomas with a mixture of allogeneic tumor cells and BCG-CWS. 1980

H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi

Experimental immunotherapy with a mixture of allogeneic tumor cells and BCG cell-wall skeleton (BCG-CWS) was carried out against established autochthonous fibrosarcomas induced by 3-methylcholanthrene (MCA) in the subcutaneous tissue of rats. The inhibitory effect on growth in the early stage, tumor-size up to 2 cm in diameter, was significantly observed. No significant difference, however, was shown as compared with the effect of treatment with allogeneic tumor cells alone. That is to say, a more effective inhibition of growth due to the addition of BCG-CWS was not demonstrated.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D008297 Male Males
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001500 BCG Vaccine An active immunizing agent and a viable avirulent attenuated strain of MYCOBACTERIUM BOVIS, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity. Bacillus Calmette Guerin Vaccine,Calmette Guerin Bacillus Vaccine,Calmette's Vaccine,Calmette Vaccine,Calmettes Vaccine,Vaccine, BCG,Vaccine, Calmette's
D012513 Sarcoma, Experimental Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA. EHS Tumor,Sarcoma, Engelbreth-Holm-Swarm,Sarcoma, Jensen,Experimental Sarcoma,Experimental Sarcomas,Sarcomas, Experimental,Engelbreth-Holm-Swarm Sarcoma,Jensen Sarcoma,Sarcoma, Engelbreth Holm Swarm,Tumor, EHS

Related Publications

H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
November 1971, Revue europeenne d'etudes cliniques et biologiques. European journal of clinical and biological research,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
June 1966, Gan,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
August 1980, International journal of radiation oncology, biology, physics,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
August 1986, Japanese journal of cancer research : Gann,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
April 1979, Cancer,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
October 1980, Kekkaku : [Tuberculosis],
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
April 1980, British journal of cancer,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
February 1978, Journal of the National Cancer Institute,
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
January 2014, Methods in molecular biology (Clifton, N.J.),
H Kudo, and M Suga, and T Waga, and M Ogasawara, and T Sato, and I Usubuchi
April 1979, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
Copied contents to your clipboard!